1 / 8

Asymptomatic HF Patients with Reduced LVEF

Asymptomatic HF Patients with Reduced LVEF. HFSA 2010 Recommendations. HFSA 2010 Practice Guideline ALVD & Exercise. Recommendation 5.1 It is recommended that all patients with asymptomatic LV dysfunction (ALVD) exercise regularly according to a physician-directed prescription to:

elwyn
Download Presentation

Asymptomatic HF Patients with Reduced LVEF

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Asymptomatic HF Patients with Reduced LVEF HFSA 2010 Recommendations

  2. HFSA 2010 Practice GuidelineALVD & Exercise • Recommendation 5.1 • It is recommended that all patients with asymptomatic LV dysfunction (ALVD) exercise regularly according to a physician-directed prescription to: • Avoid general deconditioning • Optimize weight, blood pressure and diabetes control • Reduce cardiovascular risk Strength of Evidence = C

  3. HFSA 2010 Practice GuidelineALVD & Smoking • Recommendation 5.2 • Smoking cessation is recommended in all patients, including those with ALVD. • Strength of Evidence = B

  4. HFSA 2010 Practice GuidelineALVD & Alcohol • Recommendation 5.3 • Abstinence is recommended if there is current or previous history of excessive alcohol intake. • Strength of Evidence = C

  5. HFSA 2010 Practice GuidelineALVD & Blood Pressure • Recommendation 5.4 • It is recommended that all patients with ALVD and hypertension achieve optimal blood pressure control. • Strength of Evidence = B

  6. HFSA 2010 Practice GuidelineALVD & ACE Inhibitors • Recommendation 5.5 • ACE inhibitor therapy is recommended for asymptomatic patients with reduced LVEF (<40%). • Strength of Evidence = A

  7. HFSA 2010 Practice GuidelineALVD & ARBs • Recommendation 5.6 • ARBs are recommended for asymptomatic patients with reduced LVEF who are intolerant of ACE inhibitors from cough or angioedema. Strength of Evidence = C • Routine use of the combination of ACE inhibitors and ARBs for prevention of heart failure is not recommended in this population. Strength of Evidence = C

  8. HFSA 2010 Practice GuidelineALVD & Beta Blockers • Recommendation 5.7 • Beta blocker therapy should be considered for asymptomatic patients with reduced LVEF. • Post MI Strength of Evidence = B • Non Post-MI Strength of Evidence = C

More Related